Chiesi USA, Inc., a subsidiary of the Chiesi Group, is a prominent player in the pharmaceutical industry, headquartered in the United States. Established in 1935, the company has made significant strides in developing innovative therapies, particularly in the fields of respiratory, neonatology, and rare diseases. With a strong presence across major operational regions in North America, Chiesi USA is dedicated to improving patient outcomes through its unique portfolio of products. The company is renowned for its commitment to sustainability and patient-centric solutions, offering a range of inhalation therapies and specialty pharmaceuticals that stand out for their efficacy and safety. Chiesi USA has garnered recognition for its contributions to healthcare, positioning itself as a leader in the biopharmaceutical sector, while continuously striving for excellence in research and development.
We don't have data for Chiesi USA, Inc., but we can show you information about their parent organization instead.
View parent company